TAMPA, FL / ACCESSWIRE / November 17, 2021 / TRxADE HEALTH, INC. (NASDAQ: MEDS), a healthcare IT company focused on digitizing the retail pharmacy experience by optimizing drug supply, prescription journey and patient engagement in the United States, has announced today that management will present at the LD Micro Movers virtual event, focusing on the most notable small cap names of 2021, taking place on December 1st, 2021.
Suren Ajjarapu, CEO of TRxADE HEALTH, is to facilitate a 30-minute presentation at the event, as follows:
LD micro movers
Date: Wednesday December 1, 2021
Time: 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time)
A live audio webcast will be available using the link above – an archived replay will be available after the event live on the LD Micro YouTube channel. For more information on the LD Micro Movers virtual event, please contact your LD Micro representative.
About TRxADE HEALTH, INC.
TRxADE HEALTH (NASDAQ: MEDS) is a healthcare IT company focused on digitizing the retail pharmacy experience by optimizing drug supply, prescription journey and patient engagement in the United States. . , promoting price transparency and under the Bonum Health brand, offering patient-centered telehealth services. For more information about TRxADE HEALTH, please visit the company’s IR website at Investors.trxadegroup.com.
This press release may contain forward-looking statements, including information about the views of management on the future expectations, plans and prospects of Trxade, within the meaning of federal securities laws. In particular, when used in the foregoing discussion, the words “may”, “could”, “expect”, “intend”, “plan”, “seek”, “anticipate”, ” believe “,” estimate “,” predict “,” “potential”, “continue”, “probable”, “will”, “would” and variations of these terms and similar expressions, or the negative of such terms or similar expressions are intended to identify forward-looking statements. All statements made in this press release other than those of historical fact, about an action, event or development, are forward-looking statements. known and unknown risks, uncertainties and other factors, which may cause the results of Trxade, its divisions and concepts to differ materially from those expressed or implied in these statements. adoption of our Med application Checks by partners and end users, the applications of other competitors, including governments which may make certain applications mandatory or free, our ability to gain traction for our application in the market, and the continued demand for our application; risks associated with our operations being unprofitable; claims relating to alleged infringements of the intellectual property rights of others; our ability to monetize our technological solutions; technical issues with our websites, applications and products; the risks associated with the implementation of our acquisition strategies; the challenges of the pharmaceutical supply chain related to the COVID-19 pandemic and related issues; our ability to manage our growth; the negative effects on our operations associated with the opioid pain reliever health crisis; regulatory and licensing risks; risks associated with changes in the health care environment in the United States; the state of our information systems, facilities and distribution networks; risks associated with the operations of our more established competitors; regulatory changes; healthcare fraud; COVID-19, government responses to it, economic downturns and possible recessions that result; the risks associated with the health passport market, their adoption, consumer acceptance and changes in the market for these products; changes in laws or regulations relating to our operations; privacy laws; system errors; dependence on current management; our growth strategy; and others that are included from time to time in documents filed by Trxade with the Securities and Exchange Commission, including, but not limited to, the “Risk Factors” sections in its Forms 10-K and 10-Q and in its Form 8-Ks, which it has filed, and which it files from time to time, with the United States Securities and Exchange Commission. These reports are available at www.sec.gov. Other unknown or unforeseeable factors could also have a material adverse effect on Trxade’s future results and / or could cause our actual results and financial condition to differ materially from those indicated in forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. Trxade cannot guarantee future results, activity levels, performance or achievements. Therefore, you should not place undue reliance on these forward-looking statements. We assume no obligation to publicly update any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make further updates with respect to such or other forward-looking statements.
MZ Group – MZ North America
THE SOURCE: TRxADE HEALTH, Inc.
See the source version on accesswire.com: